Publications
Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.
This activity is supported by an educational grant from AstraZeneca.
February 2022
The Interferon Gene Signature as a Clinically Relevant Biomarker in Autoimmune Rheumatic Disease
Lancet Rheumatol 2022;4:e61–72.
The interferon gene signature (IGS) fits into the paradigm of a personalised approach to care in rheumatic diseases, where an individual’s score could inform either prompt diagnosis, early use of certain therapies, or presage specific clinical phenotypes.